Selection criteria of solid organ donors in relation to infectious diseases: A Spanish consensus.


Journal

Transplantation reviews (Orlando, Fla.)
ISSN: 1557-9816
Titre abrégé: Transplant Rev (Orlando)
Pays: United States
ID NLM: 8804364

Informations de publication

Date de publication:
04 2020
Historique:
received: 21 10 2019
revised: 17 12 2019
accepted: 18 12 2019
pubmed: 1 2 2020
medline: 14 4 2021
entrez: 1 2 2020
Statut: ppublish

Résumé

The immunosuppressive treatment that recipients receive from a solid organ transplantation hinders the defensive response to infection. Its transmission from the donor can cause dysfunction or loss of the graft and even death of the recipient if proper preventive measures are not established. This potential risk should be thoroughly evaluated to minimise the risk of infection transmission from donor to recipient, especially with organ transplantation from donors with infections, without increasing graft dysfunction and morbidity and mortality in the recipient. This document aims to review current knowledge about infection screening in potential donors and offer clinical and microbiological recommendations about the use of organs from donors with infection based on available scientific evidence.

Identifiants

pubmed: 32001103
pii: S0955-470X(20)30001-X
doi: 10.1016/j.trre.2020.100528
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

100528

Informations de copyright

Copyright © 2020 Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest The authors declare that there are no conflicts of interest.

Auteurs

Oscar Len (O)

Hospital Universitari Vall d'Hebrón, Barcelona, Spain. Electronic address: oscar.len@vhir.org.

Ibai Los-Arcos (I)

Hospital Universitari Vall d'Hebrón, Barcelona, Spain.

José María Aguado (JM)

Hospital Universitario 12 de Octubre, Madrid, Spain.

Marino Blanes (M)

Hospital Universitario y Politécnico La Fe, Valencia, Spain.

Marta Bodro (M)

Hospital Clínic-IDIBAPS, Barcelona, Spain.

Jordi Carratalà (J)

Hospital Universitari de Bellvitge-IDIBELL, Barcelona, Spain.

Elisa Cordero (E)

Hospital Virgen del Rocío, Sevilla, Spain.

María Carmen Fariñas (MC)

Hospital Universitario Marqués de Valdecilla, Santander, Spain.

Mario Fernández-Ruiz (M)

Hospital Universitario 12 de Octubre, Madrid, Spain.

Jesús Fortún (J)

Hospital Universitario Ramón y Cajal, Madrid, Spain.

Joan Gavaldà (J)

Hospital Universitari Vall d'Hebrón, Barcelona, Spain.

Francisco López-Medrano (F)

Hospital Universitario 12 de Octubre, Madrid, Spain.

Rogelio López-Vélez (R)

Hospital Universitario Ramón y Cajal, Madrid, Spain.

Carlos Lumbreras (C)

Hospital Universitari Vall d'Hebrón, Barcelona, Spain.

Beatriz Mahillo (B)

Organización Nacional de Trasplantes, Madrid, Spain.

María Ángeles Marcos (MÁ)

Hospital Clínic, Barcelona, Spain.

Pilar Martin-Dávila (P)

Hospital Universitario Ramón y Cajal, Madrid, Spain.

José Miguel Montejo (JM)

Hospital Universitario de Cruces, Vizcaya, Spain.

Asunción Moreno (A)

Hospital Clínic-IDIBAPS, Barcelona, Spain.

Patricia Muñoz (P)

Hospital General Universitario Gregorio Marañón, Madrid, Spain.

Francesca Norman (F)

Hospital Universitario Ramón y Cajal, Madrid, Spain.

José Luis Pérez-Sáenz (JL)

Hospital Universitario Son Espases, Palma de Mallorca, Spain.

Tomás Pumarola (T)

Hospital Universitari Vall d'Hebrón, Barcelona, Spain.

Núria Sabé (N)

Hospital Universitari de Bellvitge-IDIBELL, Barcelona, Spain.

Rafael San-Juan (R)

Hospital Universitari Vall d'Hebrón, Barcelona, Spain.

Elisa Vidal (E)

Hospital Universitario Reina Sofía, Córdoba, Spain.

Beatriz Domínguez-Gil (B)

Organización Nacional de Trasplantes, Madrid, Spain.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH